PHARMACEUTICAL

PRIYANKA RAVAL ROLL NO:17070

INTRODUCTION
Science dealing with collection, preparation, and standardization of DRUGS, derives its name from the Greek root PHARMAKON, a drug

a company that makes and sells pharmaceuticals

Pharmacy began in Van Diemen's Land with the supply of medicines by military surgeons and dispensers As the number of free settlers grew, traders with ‘chemical knowledge' brought in shipments of medicines and chemicals The first was Michael Bates who, in 1825, established a business as 'PHARMACOPOLIST, Chemist and Druggist' in Launceston

Established the H.T. Gould & Co. Homeopathic Pharmacy in Hobart in 1881

Formal separation of medicine and pharmacy came about when the Pharmacy Act was passed in 1908
Most medicines were compounded mixtures of natural ingredients until the early 1900s, when the advent of patent medicines and manufactured tablets such as ASPIRIN AND PHENACETIN The synthesis of antibiotics and antipsychotics revolutionized drug treatment in the 1940s and 1950s In 1978 Pharmacy moved to the University of Tasmania, where it came to be ranked as one of the best pharmacy courses in Australia.

Hatton & Laws Chemists, one of the oldest pharmacy businesses still operating in Australia
Chemists were licensed by laws enacted in 1837, 1840 and 1842

INVOLVEMENT OF PHARMACEUTICALS IN INDIAn SECTOR Pharmaceuticals Other .

BIOTECHNOLOGY TAXES OF PHARMACEUTICALS PHARMACEUTICAL MARKETIN G PHARMACEUTICALS Government support & Foreign investment products sold to the consumers & Consumer prefer products .

FURTHER WILL BE CONTINUED BY MAYUR .S. AHUJA ROLL no:17091 .

-PHARMACEUTICALSBIOTECHNOLOGY .

OVERVIEW .PHARMACEUTICALS Fastest growing pharmaceuticals market. 12% annually in last 5 years. 66.400 crore in 2007-08. the domestic retail market is expected to reach around USD 13 billion by 2012. . Pharmaceuticals market was worth Rs.

. 94. India is the worlds fifthlargest producer of bulk drugs.5 Billion(RS.EXPORTS By 2012. exports are Expected to touch USD 23.000 crore ).

. about 15 patented products have been launched in the country.GLOBAL PHARMACEUTICAL COMPANIES ATTRACTED TO INDIA Since January 2005.

India ranks third in Asia-Pacific region. after Japan n Korea.OVERVIEW .BIOTECHNOLOGY India is among top 12 biotech markets globally. .

THE PHARMACEUTICAL HUB .

FURTHER WILL BE CONTINUED BY Akshay rane ROLL no:17066 .

Pharmaceuticals products sold to the consumers & Consumer prefer products. Scientifically based . Personal care 2.  Selling of products to the consumer is depend upon some Demographic changes :Consumer’s healthcare Segments:1.

 Pharmaceuticals companies expands their business beyond the over the counter market (expand business on large scale).  Promise to deliver health benefits in pharmaceuticals products.  Companies provides specific health needs or increase some dimension of performance. Personal care:- . Companies Persuade Consumers that their products are testy and healthy. 1.

.  Companies focusing on growth and profitability. Nestle company starts consumer health business.g..2. Scientific based care: Companies encouraging peoples that their products are scientifically based.  E.  Product should be organize or manage by experts persons.

.

.

 New spending due to increased in population.  Increased consumers spending. Increased focus on Public health. Consumer prefer products depends upon:- .

FURTHER WILL BE CONTINUED BY Brijesh yadav ROLL no:17088 .

is the business of advertising or otherwise promoting the sale of pharmaceuticals or drugs. sometimes called medico-marketing or pharma marketing in some countries. There is some evidence that marketing practices can negatively affect both patients and the health care profession. . Many countries have measures in place to limit advertising by pharmaceutical companies.PHARMACEUTICAL MARKETING Pharmaceutical marketing.

It was long believed that since doctors made the selection of drugs. although. until recently. An important part of these efforts was marketing to medical students. specific ads targeting the medical profession were thought to be cheaper and just as effective. such as pain relievers or allergy medicine. mass marketing was a waste of resources. has also long been practiced. Marketing of legitimate medications. mass marketing of prescription medications has been rare. ..

marketing and distribution of pharmaceuticals is regulated by the Federal Food. and Cosmetic Act and the Prescription Drug Marketing Act.In the United States. . Drug. respectively. Food and Drug Administration (FDA) regulations require all prescription drug promotion to be truthful and not misleading. based on "substantial evidence or substantial clinical experience".

SUPPLY CHAIN MANUFACTURER CNF DISTRIBUTING AGENTS MEDICAL SHOPS CONSUMER .

Also.FREE SAMPLES Free samples have been shown to affect physician prescribing behaviour. it saves time from going to a pharmacy to get it filled before treatment begins. It is argued that a benefit to free samples is the “try it before you buy it” approach.free samples allows you to find which dose and brand of medication works best before having to spend money on a filled prescription at a pharmacy. . Free Samples give immediate access to the medication and the patient can begin treatment right away.

TOP COMPANIES RANK 1 2 3 4 5 COMPANY ABBOT INDIA RANBAXY DR.REDDY LABROTERY AUROBINDO CIPLA .

WHILE THE DOMESTIC MARKET WAS 12.THE EXPENES OF SAME NOW AT 2012 IS 19.MINISTERY OF CHEMICLE & FERTILIZER THE TOTL TURNOVER OF INDIAS PHARMACEUTICLE INDUSTRY IN 2008-09 WAS 21.TOTAL EXPENDITURE THE PHARMACEUTICLE INDUSTRY IN INDIA STANDS THIRD IN THE WORLD IN CASE OF SALES. .22 MILLION. ACCORDING TO DEPARTMENT OF PHARMACEUTICLE .04 BILLION.26 MILLION.

2008 in Canada $1.7 billion a year was spent marketing drugs to physicians and in the United States $21 billion were spent in 2008. .9 billion with one estimate as high as $57 MILLION. In 2011 money spent on pharmaceutical marketing in the US was estimated at $29.

REGULATION & FRAUD MISLABELLING HIGH PRICES LOW LIFE SPAN SIDE EFFECTS LIMITED TEMPERATURE DRUGS SCAM FALSE PROMOTION. BOUNDLESS EXPENSIVE. .

4 BILLION 875 MILLION 704 MILLION FALSE PROMOTON FALSE PROMOTON MEDICARE FRAUD POOR MANF.FRAUDS COMPANY SETTLMENT FRAUDS GLAXOSMITH ELI TAP SERONO 3 BILLION 1. .

n ROLL no:17052 .FURTHER WILL BE CONTINUED BY Kamelshwaran.

Governments Support and Foreign Investments in Pharmaceutical Industries in India .

S. in many ways.. Both are filled with small start-ups while the majority of the market is controlled by a few powerful companies. . The Indian biotech sector parallels that of the U. Both are dependent upon government grants and venture capitalists for funding because neither will be commercially viable for years.[36] In both India and the U. biotech is seen as a hot field with a lot of growth potential.S. as well as in much of the globe.Comparison with the U.S. Pharmaceutical companies in both countries have recognized the potential effect that biotechnology could have on their pipelines and have responded by either investing in existing start-ups or venturing into the field themselves.

.

The International Finance Commission.”British Prime Minister Tony Blair was similarly impressed. the IFC has given $43 million to 4 projects in India.” Of the $110 million invested in 14 biotech projects investment globally.Relationship with IT Many analysts have observed that the hype around the biotech sector mirrors that of the IT sector. According to Dr. former director of the Department of Biotechnology. Manju Sharma. called India the “centerpiece of IFC’s global biotech strategy. Malaysia is also looking to India as an example for growing its own biotech industry. the private investment arm of the World Bank. . the biotech industry could become the “single largest sector for employment of skilled human resource in the years to come. Biotech colleges have been popping up around the country eager to service the pools of students that want to take advantage of a growing industry. citing the success of India’s biotech industry as the reason for his own country’s own biotech opportunities.

It established the Department of Biotechnology in 1986 under the Ministry of Science and Technology. Since then. and they are offering such goodies as exemption from VAT and other fees. . States have started to vie with one another for biotech business. India’s science minister launched a program that provides tax incentives and grants for biotech start-ups and firms seeking to expand and establishes the Biotechnology Parks Society of India to support ten biotech parks by 2010. financial assistance with patents and subsidies on everything ranging from investment to land to utilities. Previously limited to rodents. there have been a number of dispensations offered by both the central government and various states to encourage the growth of the industry.Government support The Indian government has been very supportive. animal testing was expanded to include large animals as part of the minister’s initiative.

Just two months later. An initiative passed earlier this year allowed 100% foreign direct investment without compulsory licensing from the government.S. the minister of science and technology and ocean development. Sibal returned to the U. with special emphasis on biotech. visited five cities in the U.S. to encourage investment in India.Foreign investment The government has also taken steps to encourage foreign investment in its biotech sector. a delegation headed by the Kapil Sibal. 100%of fdi is allowed in India. to unveil India’s biotech growth strategy at the BIO2005 conference in Philadelphia. In April. .

Before these potential saviors will invest significant sums in the industry.The biotech sector faces some major challenges in its quest for growth. As previously mentioned. Government grants are difficult to secure. and due to the expensive and uncertain nature of biotech research. particularly for firms that are just starting out. but it will be a while before they are up to the standards of Western investors. venture capitalists are reluctant to invest in firms that have not yet developed a commercially viable product. India hopes to solve its funding problem by attracting overseas investors and partners. Chief among them is a lack of funding. India is slowly working towards these goals. The most likely sources of funds are government grants and venture capital. Challenges . however. which is a relatively young industry in India. there needs to be better scientific and financial accountability.

FURTHER WILL BE CONTINUED BY Abhiyog patil ROLL no:17056 .

Sales and distribution 4. Procurement 2.TAXES OF PHARAMACEUTICALS • GOODS AND SERVICE TAX(GST):INTRODUCTION DUAL GST IN INDIA IMPACT ON PHARMACEUTICAL INDUSTRY:1. Pricing 5. Manufacture 3. Services 6. IT changes .

• DIRECT TAX:Tax structure Incentives to pharmaceutical sectors • INDIRECT TAXES:Custom duty Central excise duty Value added Tax and central sales tax .

Table Comparing Prices DRUGS MFG BY PRICES 2010 RISPERIDONE (Risperdal) RISEDRONATE (Risofos) Johnson & Johnson Cipla 166 366 2012 491 INCREASE IN TAX VALUE (approx) 34.45% .14% 167 50.15 % 221 33.13% CLOPIDOGREL (Noklot) PREGABALIN (Pregabit) Zydus 111 Intas Pharma 98 154 57.

45 % 57.13 % 50.GRAPHICAL IMPLEMENTATION 450 400 350 Prices 34.15 % 366 491 33.14 % 300 250 200 150 100 221 2010 167 111 98 154 2012 166 50 0 Risperidone Risedronate Clopidogrel DRUGS Pregabalin .

.

THANK YOU .